Flavanone plasma pharmacokinetics from blood orange juice in human subjects

British Journal of Nutrition

Volumn 98, Issue 1, 2007, Pages 165-172

  Gardana, Claudio ^a   Guarnieri, Serena ^a   Riso, Patrizia ^a   Simonetti, Paolo ^a   Porrini, Marisa ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Blood orange juice; Flavanones; Human studies; Pharmacokinetics

Indexed keywords

AURANTIIN; FLAVANONE; HESPERETIN; MORIN; NARINGENIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; DIETARY INTAKE; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; FEMALE; FOOD COMPOSITION; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; QUANTITATIVE ANALYSIS; SWEET ORANGE; TIME TO MAXIMUM PLASMA CONCENTRATION; VOLUNTEER;

ADULT; ANTIOXIDANTS; BEVERAGES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITRUS SINENSIS; CROSS-OVER STUDIES; DISACCHARIDES; ESTROGEN ANTAGONISTS; FEMALE; FLAVANONES; HESPERIDIN; HUMANS; INTESTINAL ABSORPTION; TANDEM MASS SPECTROMETRY;

EID: 34547982286     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507699358     Document Type: Article

References (37)

1. Choudhury R, Chowrimootoo G, Srai K, Debnam E & Rice-Evans CA (1999) Interactions of the flavonoid naringenin in the gastrointestinal tract and the influence of glycosylation. Biochem Biophys Res Commun 265, 410-415.
2. Day AJ, Canada FJ & Diaz JC (2000) Dietary flavonoid and isoflavone glycosides, am hydrolyzed by the lactase site of lactase phlorizin hydrolase. FEBS Lett 468, 166-170.
3. Day AJ, DuPont MS & Ridley S (1998) Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liverglucosidase activity. FEBS Lett 436, 71-75.
4. Edmunds KM, Holloway AC, Crankshaw DJ, Agarwal SK & Foster WG (2005) The effects of dietary phytoestrogens on aromatase activity in human endometrial stromal cells. Repr Nutr Dev 45, 709-720.
5. Erlund I, Meririnne E, Alfthan G & Aro A (2001) Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J Nutr 131, 235-241.
6. Felgines C, Talavera S, Texier O, Gil-Izquierdo A, Lamaison JL & Remesy C (2000) Bioavailability of the flavanone naringenin and its glycosides in rats. Am J Physiol 279, G1148-G1154.
7. Franke AA, Cooney RV, Henning SM & Custer LJ (2005) Bioavailability and antioxidant effects of orange juice components in humans. J Agric Food Chem 53, 5170-5178.
8. Harris DK Besselink E, Henning SM, Go VLW & Heber D (2005) Phytoestrogens induce differential estrogen receptor α- or β-mediated responses in transfected breast cancer cells. Exp Biol Med 230 558-568.
9. Heo HJ, Kim DO, Shin SC, Kim MJ, Kim BG & Shin DH (2004) Effect of antioxidant flavanone, naringenin from Citrus junos on neuroprotection. J Agric Food Chem 52, 1520-1525.
10. Hirata A, Murakami Y, Shoji M, Kadoma Y & Fujisawa S (2005) Kinetics of radical-scavenging activity of hesperetin and hesperidin and their inhibitory activity on COX-2 expression. Anticancer Res 25, 3367-3374.
11. Hollman PC, Bijsman NN, van Gameren Y, Cnossen EP, de Vries JH & Katan MB (1999) The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Rad Res 31, 569-573.
12. Ishii K, Furuta T & Kasuya Y (2000) Mass spectrometric identification and high-performance liquid chromatographic determination of a flavonoid glyqoside naringin in human urine. J Agric Food Chem 48, 56-59.
13. Justesen U, Knuthsen P & Leth T (1997) Determination of plant polyphenols in Danish foodstuffs by HPLC-UV and LC-MS detection. Cancer Lett 114, 165-167.
14. Kanaze FI, Bounartzi MI, Georgarakis M & Niopas I (2006) Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur J Clin Nutr, Published online: 18, October 2006; DOI:10.1038/ sj.ejcn.1602543.
15. Kuhnau J (1976) The flavonoids. A class of semi-essential food components: Their role in human nutrition. World Rev Nutr Diet 24, 117-191.
16. Kurowska EM & Manthey JA (2094) Hypolipidemic effects and absorption of citrus polymethoxylated flavones in hamsters with diet-induced hyper-cholesterolemia. J Agric Food Chem 52, 2879-2886.
17. Le March L (2002) Cancer preventive effects of flavonoids - a review. Biomed Pharmacother 56, 296-301.
18. Manach C, Mazur A & Scalbert A (2005a) Polyphenols and prevention of cardiovascular diseases. Curr Opinion Lipidology 16, 77-94.
19. Manach C, Morand C, Gil-Izquierdo A, Bouteloup-Demange C & Remesy C (2003) Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur J Clin Nutr 57, 235-242.
20. Manach C, Scalbert A, Morand C, Rémésy C & Jimenez L (2004) Polyphenols: Food sources and bioavailability. Am J Clin Nutr 79, 727-747.
21. Manach C, Williamson G, Morand C, Scalbert A & Rémésy C (2005b) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81, 230-242.
22. Matsumoto H, Ikoma Y, Sugiura M, Yano M & Hasegawa Y (2004) Identification and quantification of the conjugated metabolites denved from orally administered hesperidin in rat plasma. J Agric Food Chem 52, 6653-6659.
23. Matuszewski BK, Constanzer ML & Chavez-Eng CM (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 75, 3019-3030.
24. Morrissey C & Watson RW (2003) Phytoestrogens and prostate cancer. Curr Drug Targets 4, 231-241.
25. Nielsen ILF, Chee WSS, Poulsen L, Offord-Cavin E, Rasmussen SE, Frederiksen H, Ensen M, Barron D, Horcajada M-N & Willimson G (2006) Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: A randomized, double blind, crossover trial. J Nutr 136, 404-408.
26. Passamonti S, Vrhovsek U, Vanzo A & Mattivi F (2003) The stomach as a site for anthocyanins absorption from food. FEBS Lett 544, 210-213.
27. Pietta PG, Simonetti P. Roggi C, Brusamolino A, Pellegrini N, Maccarini L & Testolin G (1996) Dietary flavonoids and oxidative stress. In Natural Antioxidants and Food Quality in Atherosclerosis and Cancer Prevention, pp. 249-255 [JT Kumpulainen and JT Salonen, editors]. Cambridge: Royal Society of Chemistry.
28. Riso P, Visioli F, Gardana C, Grande S, Brusamolino A, Galvano F, Galvano G & Porrini M (2005) Effects of blood orange juice intake on antioxidant bioavailability and on different markers related to oxidative stress. J Agric Food Chem 53, 941-947.
29. Robards K, Li X, Antolovich M & Boyd S (1997) Characterization of citrus by chromatographic analysis of flavonoids. J Sci Food Agric 75 87-101.
30. Rotelli AE, Guardia T, Juarez AO, de la Rocha NE & Pelzer LE (2003) Comparative study of flavonoids in experimental models of inflammation. Pharm Res 48, 601-606.
31. Sapson L, Rimm E, Hollman PC, de Vries JH & Katan MB (2002) Flavonol and flavone intakes in US health professionals. J Am Diet Assoc 102 1414-1420.
32. Scalbert A, Manach C, Morand C, Remesy C & Jimenez L (2005) Dietary polyphenols and the prevention of diseases. Critical Rev Food Sci Nutr 45, 287-306.
33. Shen SC, Ko CK Tseng SW, Tsai SH & Chen YC (2004) Structurally related antitumor effects of flavanones in vitro and in vivo: Involvement of caspase 3 activation, p21 gene expression, and reactive oxygen species production. Toxicol App Pharm 197, 84-95.
34. Spencer JP, Chowrimootoo G, Choudhury R, Debnam ES, Srai SK & Rice-Evans C (1999) The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Lett 458, 224-230.
35. Talavera S, Felgines C, Texier O, Besson C, Lamaison JL & Remesy C (2003) Anthocyanins are efficiently absorbed from the stomach in anaesthetized rats. J Nutr 133, 4178-4182
36. Tomas-Barberan FA & Clifford MN (2000) Flavanones, chalcones and dihydrochalcones - nature, occurrence and dietary burden. J Sci Food Agric 80, 1073-1080.
37. Walgren RA, Lin JT, Kinne RK & Walle T (2000) Cellular uptake of dietary flavonoid quercetin 4′-β-glucoside by sodium-dependent glucose transporter SGLT1. J Pharmacol Exp Ther 294, 837-843.